---
figid: PMC9105968__ijms-23-05248-g005
figtitle: Lactoferrin as a Human Genome “Guardian”—An Overall Point of View
organisms:
- Escherichia coli
- Staphylococcus aureus
- Pseudomonas aeruginosa
- Helicobacter pylori
- Listeria monocytogenes
- Shigella flexneri
- Lactococcus lactis
- Streptococcus mutans
- Neisseria gonorrhoeae
- Mycoplasmopsis fermentans
- Saccharomyces cerevisiae
- Nicotiana tabacum
- Oryza sativa
- Candida dubliniensis
- Severe acute respiratory syndrome coronavirus 2
- Hepatitis B virus
- Adenoviridae
- Candida albicans
- Coronaviridae
- Human immunodeficiency virus
- Human papillomavirus
- Orthomyxoviridae
- Human betaherpesvirus 5
- Human T-cell leukemia virus type I
- Aspergillus niger
- Komagataella pastoris
- Nakaseomyces glabratus
- Tectaria cicutaria
- Bos taurus
- Canis lupus familiaris
- Sus scrofa
- Ovis aries
- Camelus bactrianus
- Mus musculus
- Rattus norvegicus
- Entamoeba histolytica
- Giardia intestinalis
- Homo sapiens
- Gallus gallus
- NA
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Sus scrofa
- Homo sapiens
- Canis lupus familiaris
- Ovis aries
- Bos taurus
- Camelus bactrianus
- Gallus gallus
- Drosophila melanogaster
pmcid: PMC9105968
filename: ijms-23-05248-g005.jpg
figlink: /pmc/articles/PMC9105968/figure/ijms-23-05248-f005/
number: F5
caption: 'Modulation of cell cycle by bLF and rhLF demonstrated on the example of
  different cancer cells lines. During the cell cycle, LF can inhibit or activate
  several checkpoint regulators such as: cyclin-dependent kinase (CDK), and their
  associated inhibitor partners of the Cip/Kip family proteins (p21, p27), DNA damage
  response genes (p53) or mTOR/S6K pathway. In response to bLF and rhLF cancer target
  cells arrest in G0/G1 phase (e.g., HSC3 cells, head and neck cancer line), G1/G2
  phase (e.g., OSCC, MDA-MD-231 cells, nasopharyngeal carcinoma cells), G2/M phase
  (e.g., ALL cells) or S phase (e.g., MDA-MB-231 cells, A549 cells). Key molecules
  that lead to cell cycle arrest are indicated by the red arrows. Illustration was
  created in BioRender.com (accessed on 21 April 2022).'
papertitle: Lactoferrin as a Human Genome “Guardian”—An Overall Point of View.
reftext: Iwona Bukowska-Ośko, et al. Int J Mol Sci. 2022 May;23(9):5248.
year: '2022'
doi: 10.3390/ijms23095248
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: lactoferrin | oxidative stress | DNA damage | DNA glycosylases
automl_pathway: 0.8012624
figid_alias: PMC9105968__F5
figtype: Figure
redirect_from: /figures/PMC9105968__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9105968__ijms-23-05248-g005.html
  '@type': Dataset
  description: 'Modulation of cell cycle by bLF and rhLF demonstrated on the example
    of different cancer cells lines. During the cell cycle, LF can inhibit or activate
    several checkpoint regulators such as: cyclin-dependent kinase (CDK), and their
    associated inhibitor partners of the Cip/Kip family proteins (p21, p27), DNA damage
    response genes (p53) or mTOR/S6K pathway. In response to bLF and rhLF cancer target
    cells arrest in G0/G1 phase (e.g., HSC3 cells, head and neck cancer line), G1/G2
    phase (e.g., OSCC, MDA-MD-231 cells, nasopharyngeal carcinoma cells), G2/M phase
    (e.g., ALL cells) or S phase (e.g., MDA-MB-231 cells, A549 cells). Key molecules
    that lead to cell cycle arrest are indicated by the red arrows. Illustration was
    created in BioRender.com (accessed on 21 April 2022).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Gabrg2
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Cdk1
  - Cdkn1b
  - Dctn6
  - Psmd9
  - Trp53
  - gs
  - Gs
  - Mtor
  - Cdk6
  - Cdk4
  - Cdk2
  - Kras
  - Ldha
  - Tmed7
  - Tp53
  - Defb1
  - Line
  - CDK1
  - GM
  - TP53
  - MTOR
  - CDK6
  - CDK4
  - CDK2
  - WARS1
  - DNAJB7
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - CCNB1
  - CCNB2
  - CCNB3
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - BCR
  - TP63
  - TP73
  - CCNA1
  - CCNA2
  - GNAS
  - GNAL
  - CCND1
  - CCND2
  - CCND3
  - CCNE1
  - CCNE2
  - CDKN1B
  - LanB2
  - anon-70Db
  - Ggamma1
  - anon-70Dc
  - Hsc70-3
  - dap
  - CycB
  - DCTN6-p27
  - CG9588
  - gm
  - p53
  - betaTub60D
  - hth
  - CycA
  - Orai
  - Tor
  - CycD
  - rb
  - CycE
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Go
---
